Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Kyung Jin Yoo"'
Autor:
George Fromm, Taylor Schreiber, Kellsey Johannes, Arpita Patel, Suresh De Silva, Kyung Jin Yoo, Casey Shuptrine, Zach Opheim, Haley Andreasen, Jaya Miriyala
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/a1e23bf92dc9404bb0e3a57ef5b50742
Autor:
Kyung Jin Yoo, Jeong Ki Kim
Publikováno v:
The Korean Health & Fundamental Medical Science Society. 15:86-91
Autor:
Taylor H. Schreiber, Kaiwen Huang, Kyung Jin Yoo, Arpita Patel, Kellsey Johannes, Casey W. Shuptrine, George Fromm, Suresh de Silva
Disrupting the binding of CD47 to SIRPα has emerged as a promising immunotherapeutic strategy for advanced cancers by potentiating antibody-dependent cellular phagocytosis (ADCP) of targeted antibodies. Preclinically, CD47/SIRPα blockade induces an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28f925ce040d128dd8677e8012432388
https://doi.org/10.1158/2326-6066.c.6550477
https://doi.org/10.1158/2326-6066.c.6550477
Autor:
Taylor H. Schreiber, Kaiwen Huang, Kyung Jin Yoo, Arpita Patel, Kellsey Johannes, Casey W. Shuptrine, George Fromm, Suresh de Silva
Supplementary Figures 1-6 and Supplementary Tables 1-3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::209c1f14ca5731dfd580e06dd07646e7
https://doi.org/10.1158/2326-6066.22543954
https://doi.org/10.1158/2326-6066.22543954
Autor:
Kyung-Jin Yoo, Jeong-Ki Kim
Publikováno v:
Korean Aging-Frendly Industry Association. 13:1-9
Autor:
Kyung-Jin Yoo, Jeong-Ki Kim
Publikováno v:
Society of Occupational Therapy for the Aged and Dementia. 15:35-44
Autor:
Anne Y. Lai, Arpita Patel, Faraha Brewer, Kinsley Evans, Kellsey Johannes, Louis E. González, Kyung Jin Yoo, George Fromm, Keith Wilson, Taylor H. Schreiber, Suresh de Silva
Publikováno v:
J Immunol
Vγ9Vδ2+ T cell–targeted immunotherapy is of interest to harness its MHC-independent cytotoxic potential against a variety of cancers. Recent studies have identified heterodimeric butyrophilin (BTN) 2A1 and BTN3A1 as the molecular entity providing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61f09dab9f4b3b04d15e838c2cfb4e10
https://europepmc.org/articles/PMC9527206/
https://europepmc.org/articles/PMC9527206/
Autor:
Kyung Jin Yoo, Kellsey Johannes, Louis E. González, Arpita Patel, Casey W. Shuptrine, Zachary Opheim, Karen Lenz, Kristen Campbell, Thuy-Ai Nguyen, Jayalakshmi Miriyala, Connor Smith, Ashlyn McGuire, Yi-Hsuan Tsai, Fatima Rangwala, Suresh de Silva, Taylor H. Schreiber, George Fromm
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 209(3)
Coinhibition of TIGIT (T cell immunoreceptor with Ig and ITIM domains) and PD-1/PD-L1 (PD-1/L1) may improve response rates compared with monotherapy PD-1/L1 blockade in checkpoint naive non–small cell lung cancer with PD-L1 expression >50%. TIGIT m
Autor:
Kyung Jin Yoo, Louis Gonzalez, Kellsey Johannes, Jayalakshmi Miriyala, Karen Lenz, Kristen Campbell, Suresh de Silva, Taylor H. Schreiber, George J. Fromm
Publikováno v:
Cancer Research. 82:4214-4214
Although increased TIGIT expression on TILs is associated with poor survival in patients with cancer, monotherapy TIGIT antibody blockade has not yet demonstrated significant clinical activity. PD-1 is commonly co-expressed on TILs, and PD-1 mediated
Autor:
Anne Lai, Arpita Patel, Faraha Brewer, Kinsley Evans, Kellsey Johannes, Louis Gonzalez, Kyung Jin Yoo, George Fromm, Keith Wilson, Taylor H. Schreiber, Suresh de Silva
Publikováno v:
Cancer Research. 82:3514-3514
A primary mechanism of cancer immunotherapy resistance involves downregulation of specific antigens or major histocompatibility complex (MHC) based antigen presentation, which renders tumor cells invisible to αβ T cells, but not γδ T cells. Recen